This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0439U only for Epi+Gen CHD™ from Cardio Diagnostics Inc. The test uses a whole–blood sample to analyze five single–nucleotide polymorphisms (SNPs) and three DNA methylation markers in specific genes. The methodology is quantitative polymerase chain reaction (qPCR) and digital PCR. The test includes an algorithmic analysis to report the patient’s three–year risk of symptomatic coronary heart disease.
For clinical responsibility, terminology, tips and additional info
start codify free trial.